Search

Your search keyword '"Mercieca-Bebber R"' showing total 128 results

Search Constraints

Start Over You searched for: Author "Mercieca-Bebber R" Remove constraint Author: "Mercieca-Bebber R"
128 results on '"Mercieca-Bebber R"'

Search Results

1. An Updated Systematic Review of Quantitative Studies Assessing Anxiety, Depression, Fear of Cancer Recurrence or Psychological Distress in Testicular Cancer Survivors

2. The importance of patient-reported outcomes in clinical trials and strategies for future optimization

5. The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set

8. Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30

9. Improving the patient-reported outcome sections of clinical trial protocols: a mixed methods evaluation of educational workshops

10. TROG 14.04: Multicentre Study of Feasibility and Impact on Anxiety of DIBH in Breast Cancer Patients.

11. Additional file 1 of Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma

12. Additional file 3 of Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma

14. Large expert-curated database for benchmarking document similarity detection in biomedical literature search

15. The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set

16. PH-0225 TROG 14.04: Multicentre study of feasibility and impact on anxiety of DIBH in breast cancer patients

17. The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set

18. The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set

19. United States Utility Algorithm for the EORTC QLU-C10D, a Multiattribute Utility Instrument Based on a Cancer-Specific Quality-of-Life Instrument.

20. A systematic review of the impact of contemporary treatment modalities for cervical cancer on women's self-reported health-related quality of life

22. 1430P Patient-reported outcome (PRO) results from AGITG DOCTOR: A randomised phase II trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma

24. Large expert-curated database for benchmarking document similarity detection in biomedical literature search

26. Patient, client, consumer, survivor or other alternatives? A scoping review of preferred terms for labelling individuals who access healthcare across settings

27. Large expert-curated database for benchmarking document similarity detection in biomedical literature search

28. Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30

29. Preliminary evidence on the uptake, use and benefits of the CONSORT-PRO extension.

30. Australian utility weights for the EORTC QLU-C10D, a multi-attribute utility instrument derived from the cancer-specific quality of life questionnaire, EORTC QLQ-C30

33. Large expert-curated database for benchmarking document similarity detection in biomedical literature search

34. Acceptability and timing considerations when administering patient-reported outcome measures (PROMs) among people with chronic health conditions who are culturally and linguistically diverse (CALD): a qualitative study protocol.

35. Relationship between reasons for intermittent missing patient-reported outcomes data and missing data mechanisms.

36. Estimating survival scenarios in advanced or metastatic gastric and oesophageal adenocarcinoma: a systematic review of randomized-controlled trials.

37. Recommendations to address respondent burden associated with patient-reported outcome assessment.

38. A systematic review of the patient reported outcomes that affect patients with muscle invasive bladder cancer after radical cystectomy and urinary diversion.

39. Relationship between survivorship care plans and unmet information needs, quality of life, satisfaction with care, and propensity to engage with, and attend, follow-up care.

40. Prognostic value of patient reported outcomes in advanced gastro-oesophageal cancer: a systematic review.

41. Development of consensus-based considerations for use of adult proxy reporting: an ISOQOL task force initiative.

42. Patient-Reported Bowel, Urinary, and Sexual Outcomes After Laparoscopic-Assisted Resection or Open Resection for Rectal Cancer: The Australasian Laparoscopic Cancer of the Rectum Randomized Clinical Trial (ALaCart).

43. Health-related quality of life of Australians during the 2020 COVID-19 pandemic: a comparison with pre-pandemic data and factors associated with poor outcomes.

44. Knowledge translation concerns for the CONSORT-PRO extension reporting guidance: a review of reviews.

45. Improving the patient-reported outcome sections of clinical trial protocols: a mixed methods evaluation of educational workshops.

46. Ethical Considerations for the Inclusion of Patient-Reported Outcomes in Clinical Research: The PRO Ethics Guidelines.

47. The use of proxies and proxy-reported measures: a report of the international society for quality of life research (ISOQOL) proxy task force.

48. Clinical Trial Protocol for HyNOVA: Hyperthermic and Normothermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III epithelial OVArian, fallopian tube and primary peritoneal cancer (ANZGOG1901/2020).

49. How is quality of life defined and assessed in published research?

50. International perspectives on suboptimal patient-reported outcome trial design and reporting in cancer clinical trials: A qualitative study.

Catalog

Books, media, physical & digital resources